2019
DOI: 10.31363/2313-7053-2019-4-1-84-85
|View full text |Cite
|
Sign up to set email alerts
|

Dopamine transporter knockout rats as the new preclinical model of hyper- and hypo-dopaminergic disorders

Abstract: Rat line lacking the dopamine transporter (DAT-KO rats) was recently developed. Lack of DAT in these mutants manifests behaviorally as spontaneous hyperactivity and cognitive deficits. It has been shown that d-amphetamine and methylphenidate paradoxically calm down these animals. Also, the inhibition of dopamine synthesis in DAT-KO rats represents a straightforward approach for developing the model of severe dopamine deficiency exhibiting characteristic akinetic phenotype which can be reversed by treatment wit… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
7
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(8 citation statements)
references
References 0 publications
1
7
0
Order By: Relevance
“…This fact might be also explained by their hyperactivity and perseverations. The inability of DAT-KO rats to immediately focus their attention on the objects presented may be also related to their attention deficit described earlier (Sukhanov et al, 2019).…”
Section: Discussionmentioning
confidence: 77%
See 2 more Smart Citations
“…This fact might be also explained by their hyperactivity and perseverations. The inability of DAT-KO rats to immediately focus their attention on the objects presented may be also related to their attention deficit described earlier (Sukhanov et al, 2019).…”
Section: Discussionmentioning
confidence: 77%
“…The strain of rats with deletion of DAT gene (DAT-KO rats) was developed ( Leo et al, 2018a ) to investigate various aspects of DA system dysfunctions with a particular emphasis on cognitive disorders ( Vengeliene et al, 2017 ; Leo et al, 2018b ; Sukhanov et al, 2019 ). DAT-KO rats were described to have increased locomotor activity, an impaired sensorimotor gating, a deficit in operant nose-poke responding reinforced by food pellets, and decreased Y-maze spontaneous alternation.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Although GBR 12909 also showed proarrhythmic potential in humans, indicating prolonged QTc interval on electrocardiogram (Rothman et al, 2008), clinical GBR 12909 safety studies did not reveal behavioral alterations in humans, unlike other DAT blockers (e.g., cocaine) (Preti, 2000;Tella et al, 1996). However, acute GBR 12909 induced overt hypolocomotion in adult zebrafish, a profile in line with some genetic (e.g., rodent DAT knockout (Cinque et al, 2018;Spielewoy et al, 2001)) or pharmacological (e.g., amphetamine-treated rodents (Cinque et al, 2018;Sukhanov et al, 2019) and zebrafish (Cleal et al, 2021b)) models of DAT deficits. Furthermore, GBR 12909-induced hypolocomotion in zebrafish is unlikely due to putative cardiotoxicity, as no data from studying other cardiotoxic agents link hypolocomotion and cardiotoxicity (Heideman et al, 2005;Wiprich et al, 2020;Yang et al, 2022).…”
Section: Discussionmentioning
confidence: 90%
“…The DAT‐KO rat line was developed (Leo, Sukhanov & Gainetdinov, 2018) to investigate various aspects of DA system dysfunction (Sukhanov et al, 2019; Vengeliene et al, 2017). Over the past few years, adult DAT‐KO rats were described to have increased locomotor activity, impaired sensorimotor gating, deficits in operant nose‐poke responding reinforced by food pellets, decreased Y‐maze spontaneous alternation, impairments of working memory, and significant dysregulation in frontostriatal brain‐derived neurotrophic factor function (Adinolfi et al, 2018; Cinque et al, 2018; Kurzina et al, 2020).…”
Section: Discussionmentioning
confidence: 99%